<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03464747</url>
  </required_header>
  <id_info>
    <org_study_id>IRB : 16.09.02</org_study_id>
    <nct_id>NCT03464747</nct_id>
  </id_info>
  <brief_title>Continuous Central Venous Lactate Monitoring by Intravascular Microdialysis : a Comparison to Sequential Arterial Lactate Measurement During Shock.</brief_title>
  <official_title>Continuous Central Venous Lactate Monitoring by Intravascular Microdialysis : a Comparison to Sequential Arterial Lactate Measurement During Shock.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Nīmes</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Nīmes</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      During shock, arterial hypotension, inadequate cardiac output and microcirculatory&#xD;
      alterations lead to tissue hypoxia, multiple organ failure and death. Arterial lactate is&#xD;
      considered as the best marker of tissue hypoxia. A lactate decrease during the first 6 hour&#xD;
      is strongly associated with better outcome and may be used as a target for assessing the&#xD;
      efficiency of shock resuscitation.&#xD;
&#xD;
      The EIRUS system (Maquet Critical Care AB, 17154, Solna, Sweden) is a new device allowing the&#xD;
      continuous measurement of venous lactate through a central venous catheter.&#xD;
&#xD;
      However, before being used extensively, such device needs to be evaluated concerning its&#xD;
      accuracy. The aim of the present study is to assess the reliability of this device.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 17, 2017</start_date>
  <completion_date type="Actual">June 15, 2018</completion_date>
  <primary_completion_date type="Actual">June 15, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Agreement</measure>
    <time_frame>Every 4hours for 48hours</time_frame>
    <description>Agreement between sequential arterial blood lactate measurement and continuous venous lactate obtained by microdialysis</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Interchangeability</measure>
    <time_frame>Every 4hours for 48hours</time_frame>
    <description>Interchangeability of the variations of the two methods using the trend interchangeability method</description>
  </secondary_outcome>
  <enrollment type="Actual">29</enrollment>
  <condition>Shock</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>EIRUS system (Maquet Critical Care AB, 17154, Solna, Sweden)</intervention_name>
    <description>continuous measurement of venous lactate through a central venous catheter by microdialysis</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        ICU patients&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Acute circulatory failure defined as : systolic blood pressure&lt;90mmHg or mean arterial&#xD;
        pressure &lt;65mmHg and blood lactate &gt; 2mmol/L&#xD;
&#xD;
        Exclusion Criteria: Pregnant women&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>CHU de Nîmes - Hôpital Universitaire Carémeau</name>
      <address>
        <city>Nîmes Cedex 9</city>
        <zip>30029</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>March 8, 2018</study_first_submitted>
  <study_first_submitted_qc>March 8, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 14, 2018</study_first_posted>
  <last_update_submitted>August 11, 2020</last_update_submitted>
  <last_update_submitted_qc>August 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 12, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Lactic Acid</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Shock</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

